iShares Biotechnology ETF (NASDAQ:IBB) Stock Holdings Lowered by Sunbelt Securities Inc.

Sunbelt Securities Inc. cut its position in iShares Biotechnology ETF (NASDAQ:IBB) by 25.6% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 670 shares of the financial services provider’s stock after selling 230 shares during the quarter. Sunbelt Securities Inc.’s holdings in iShares Biotechnology ETF were worth $97,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. BNP Paribas Financial Markets grew its stake in shares of iShares Biotechnology ETF by 29.3% in the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after purchasing an additional 538,899 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its position in iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares in the last quarter. State of Michigan Retirement System grew its position in iShares Biotechnology ETF by 150.0% in the 2nd quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock valued at $17,158,000 after buying an additional 75,000 shares in the last quarter. Aristides Capital LLC acquired a new position in iShares Biotechnology ETF during the 2nd quarter valued at about $9,180,000. Finally, Sanctuary Advisors LLC bought a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth about $8,118,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 0.8 %

iShares Biotechnology ETF stock opened at $136.61 on Monday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The firm has a 50 day simple moving average of $141.84 and a 200-day simple moving average of $142.38.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.